No Detail Found!

The combination of crocin with cisplatin suppresses growth of gastric carcinoma cell line BGC-823 and promotes cell apoptosis

Author(s)
Yushuang Luo Research Center for High Altitude Medicine, Qinghai University, Medical School of Medicine, Xining, China; Department of Oncology, Affiliated Hospital of Qinghai University, Kunlong Road 16, Tongren Road 29, Xining, China
Sen Cui Hematology Department, Affiliated Hospital of Qinghai University,Xining,China
Feng Tang Research Center for High Altitude Medicine, Qinghai University, Medical School of Medicine,Xining,China
Cunfang Shen Department of Oncology, Affiliated Hospital of Qinghai University,Kunlong Road 16, Tongren Road 29, Xining,China
Yujuan Qi Department of Oncology, Affiliated Hospital of Qinghai University,Kunlong Road 16, Tongren Road 29, Xining,China
Dianxiang Lu Research Center for High Altitude Medicine, Qinghai University, Medical School of Medicine,Xining,China
Lan Ma Research Center for High Altitude Medicine, Qinghai University, Medical School of Medicine,Xining,China
Yingzhong Yang Research Center for High Altitude Medicine, Qinghai University, Medical School of Medicine,Xining,China
Yan Li Department of Oncology, Affiliated Hospital of Qinghai University,Kunlong Road 16, Tongren Road 29, Xining,China
Rong Chen Department of Oncology, Affiliated Hospital of Qinghai University,Kunlong Road 16, Tongren Road 29, Xining,China
GE Ri-li Research Center for High Altitude Medicine, Qinghai University, Medical School of Medicine,Xining,China
Abstract
This study aimed to investigate the efficacy of crocin alone and in combination with cisplatin in the therapy of gastric carcinoma cells. In this study, human gastric carcinoma cell line BGC-823 was purchased and maintained in standard condition. Crocin, cisplatin and crocin plus cisplatin diluted to different concentrations were added into medium, respectively. MTT assay and flow cytometry were performed to test the anti-proliferation effects and apoptosis rates of cells, respectively. In addition, quantitative RT-PCR was used to detect the mRNA expression of apoptosisrelated genes, such as p53, Bax and Bcl-2. After treated with different concentrations of crocin, the inhibition ratio and apoptosis rate of BGC-823 cells were not significantly changed. However, the tumor cell inhibition ratio and apoptosis rate in crocin plus cisplatin group were significantly higher than that in cisplatin, crocin and control group (p<0.05). The treatment of crocin plus cisplatin significantly increased the expression of p53 and Bax (p< 0.05), and significantly decreased the Bcl-2 expression (p<0.05). Collectively, our data demonstrated for the first time that crocin plus cisplatin may be used as a new anticancer drug for the treatment of gastric cancer.
Publication Details
Page(s) 1629-1634
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 30, Issue: 5, Year: 2017

Request the full text from PASTIC

Keywords
gastric cancer, Cisplatin, Apoptosis, cell proliferation, crocin
0

Citations

0

Downloads

60

Views